Back to 
Woodline Partners LP
Woodline Partners LP
KNSA
Showing 0 of 6 quarters
Position history for Woodline Partners LP's holdings in KINIKSA PHARMACEUTICALS-A
No. Woodline Partners exited its KNSA (Kiniksa Pharmaceuticals) position in Q3 2023. Its Q2 2023 13F listed 290,001 shares worth $4.1M. Woodline Partners first reported KNSA in Q3 2021 and held it in 3 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.